Bill
H 4555
Requires public and contracted insurers to cover standard fertility preservation for patients with medical/genetic conditions that may impair fertility.
Status and procedural posture
- Bill number: H.4555 (Commonwealth of Massachusetts)
- Filed: 09/19/2025; introduced in the House and reported from the Committee on Financial Services on 09/29/2025. Reported favorably and referred to the Committee on Health Care Financing.
- Note: the document as provided also contains the text of an unrelated House resolution (filed 05/08/2025) recognizing “TiffanyJ.” That resolution appears to be from another jurisdiction and is not related to the Massachusetts legislative text described below.
Purpose and intent
H.4555 would (1) require public and contracted health plans to cover fertility preservation services when a diagnosed medical or genetic condition (including those and treatments that are likely to impair fertility) threatens reproductive capacity, and (2) establish a Statewide Steering Committee on Sickle Cell Disease (SCD) within the Massachusetts Department of Public Health (DPH) to coordinate care, education, and services for people with SCD.
Key provisions — Insurance coverage for fertility preservation (proposed insertion: G.L. c.118E, new §10AA)
- Definitions: “Directly or indirectly cause impairment of fertility” is tied to standards from professional bodies (American Society for Reproductive Medicine, ASCO, or comparable organizations). “Standard fertility preservation services” are those recommended by board-certified OB/GYNs, reproductive endocrinologists or other physicians consistent with prevailing professional guidelines.
- Coverage requirement: The Division (DPH) and its contracted health insurers, health plans, HMOs, behavioral health management firms and third‑party administrators under contract to Medicaid managed care organizations or primary care clinician plans must cover standard fertility preservation services — including procurement, cryopreservation and storage of gametes, embryos or other reproductive tissue — for covered persons with diagnosed medical/genetic conditions that may impair fertility.
- Parity: Coverage must be provided to the same extent as other pregnancy-related procedures.
Key provisions — Statewide Sickle Cell Disease (SCD) Steering Committee (within DPH)
- Establishes a Steering Committee on SCD with specified membership: representatives from the Massachusetts Sickle Cell Disease Association, medical professionals from major SCD treatment centers, community health worker and social work associations, experts on biological and psychosocial aspects, education department representatives, legislative caucus representatives, SCD patients and family members, and a representative with racial health disparities expertise. Nongovernmental reps serve staggered 3‑year terms; vacancies filled within 60 days.
- Duties and powers: build institutional and community partnerships; create statewide stakeholder and culturally competent networks (including school staff and home health providers); oversee development of educational materials for patients, providers and the public; identify funding sources (state, federal, local, private); investigate and report on a standard of multidisciplinary care; form subcommittees.
- DPH authority (in consultation with the Committee) to provide services including: educational programs on rights and supports for people with SCD, social services support via social workers/community health workers, hemoglobin electrophoresis/genetic testing, genetic counseling, assistance with reimbursement for SCD-related medical expenses, and counseling/education after newborn screening.
Who would be affected
- Patients with sickle cell disease and other medical/genetic conditions that may impair fertility (and their families).
- Public and private health insurers and managed-care contractors in Massachusetts, including Medicaid MCOs and third‑party administrators (who would be required to provide fertility preservation coverage).
- Health care providers (reproductive specialists, SCD specialists, primary care clinicians), schools and school nurses (through education/coordination duties), community-based organizations, and state public health agencies involved in SCD care coordination.
- The state budget and insurers could see increased expenditures associated with expanded coverage and implementation of committee recommendations; the bill seeks to identify funding sources including state, federal and private funds.
Potential impact and considerations
- Improved access to fertility preservation for patients whose disease or treatments threaten reproductive capacity, aligning coverage with professional medical guidelines.
- Creation of a centralized, multidisciplinary mechanism to coordinate SCD care statewide, which could improve education, standardization of care, and linkage to services (testing, counseling, reimbursement help).
- Implementation will require administrative work by DPH, appointments to the Steering Committee, and potential appropriation or identification of funds to support committee activities and services. Insurers may face new mandatory coverage obligations; scope and cost will depend on rulemaking/implementation details.
Document note
- The packet also contains a separate House resolution titled “TO RECOGNIZE AND COMMEND TIFFANYJ…” (filed 05/08/2025) honoring a community leader and her program “Beauty, You Are Boot Camp.” That resolution is ceremonial and appears unrelated to the Massachusetts statutory bill summarized above.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
